Advertisement
Screener

Stonepine Capital Management, LLC Historic Quarter Change: USA Other Stocks, Reduced

Stonepine Capital Management, LLC historic quarter change: USA Other Stocks, Reduced

In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), over 13 quarters from 2015-12-31 to 2026-06-30, Stonepine Capital Management, LLC opened 39 positions, added to 26, reduced 17 and sold out of 39.

  • Q3 2025: Stock INDIVIOR PLC; Country of operation —; Class ORD; Shares before 350,000.
  • Q1 2025: Stock INDIVIOR PLC; Country of operation —; Class ORD; Shares before 305,000.
  • Q1 2025: Stock ADICET BIO INC; Country of operation United States; Class COM; Shares before 700,000.
  • Q4 2024: Stock REVANCE THERAPEUTICS INC; Country of operation United States; Class COM; Shares before 820,000.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1440771), 13 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-17); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-14); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-13); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-13); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-13); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-14); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-13); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-21); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-11); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-11). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2015-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q3 2025INDIVIOR PLC
CUSIP G4766E116
ORD350,000100,000-250,000$5,159,000$2,411,000-$2,748,0002025-11-13
Q1 2025INDIVIOR PLC
CUSIP G4766E116
ORD305,000304,000-1,000$3,791,150$2,897,120-$894,0302025-05-14
Q1 2025ADICET BIO INC
CUSIP 007002108
United StatesCOM700,000508,266-191,734$673,400$203,500-$469,9002025-05-14
Q4 2024REVANCE THERAPEUTICS INC
CUSIP 761330109
United StatesCOM820,00023,264-796,736$4,255,800$70,723-$4,185,0772025-02-14
Q3 2024REVANCE THERAPEUTICS INC
CUSIP 761330109
United StatesCOM2,800,000820,000-1,980,000$7,196,000$4,255,800-$2,940,2002024-11-13
Q2 2024ALIMERA SCIENCES INC
CUSIP 016259202
United StatesCOM NEW4,051,0723,511,816-539,256$15,799,181$19,525,697+$3,726,5162024-08-21
Q1 2024SCYNEXIS INC
CUSIP 811292200
United StatesCOM NEW1,355,18695,637-1,259,549$3,022,065$140,586-$2,881,4792024-05-15
Q3 2016Derma Sciences, Inc.
CUSIP 249827502
COM283,30698,064-185,242$1,116,000$458,000-$658,0002016-11-14
Q3 2016Cutera, Inc.
CUSIP 232109108
United StatesCOM438,000400,000-38,000$4,910,000$4,768,000-$142,0002016-11-14
Q2 2016SCICLONE PHARMACEUTICALS INC
CUSIP 80862K104
COM2,048,6381,082,532-966,106$22,535,000$14,138,000-$8,397,0002016-08-11
Q2 2016PAIN THERAPEUTICS INC
CUSIP 69562K100
COM3,530,4012,837,878-692,523$7,873,000$6,215,000-$1,658,0002016-08-11
Q2 2016TOBIRA THERAPEUTICS INC
CUSIP 88883P101
United StatesCOM832,977637,567-195,410$6,814,000$8,008,000+$1,194,0002016-08-11
Q2 2016DERMA SCIENCES INC
CUSIP 249827502
COM507,799283,306-224,493$1,574,000$1,116,000-$458,0002016-08-11
Q1 2016CTI BIOPHARMA CORP
CUSIP 12648L106
COM10,698,6183,743,340-6,955,278$13,159,000$1,989,000-$11,170,0002016-05-11
Q1 2016SAGENT PHARMACEUTICALS INC
CUSIP 786692103
COM462,824333,065-129,759$7,364,000$4,053,000-$3,311,0002016-05-11
Q1 2016PAIN THERAPEUTICS INC
CUSIP 69562K100
COM3,575,0003,530,401-44,599$6,256,000$7,873,000+$1,617,0002016-05-11
Q1 2016TOBIRA THERAPEUTICS INC
CUSIP 88883P101
United StatesCOM833,377832,977-400$8,375,000$6,814,000-$1,561,0002016-05-11

Similar Firms

Firm NameCountry13F ValueHoldings
Porter White Investment Advisors, Inc.United States$0.250B40
Bigelow Investment Advisors, LLCUnited States$0.250B153
TMT General Partner LtdHong Kong$0.250B3
EVR Research LPUnited States$0.250B30
FIDELITY D & D BANCORP INCUnited States$0.249B166
VPR Management LLCUnited States$0.250B65
Parker Financial LLCUnited States$0.250B37
Emprise BankUnited States$0.249B107
Step Capital Management Pte. Ltd.Singapore$0.249B27
Chicago Wealth Management, Inc.United States$0.251B59